Xenotech LLC
Kansas City, KS Doing business as Sekisui-Xenotech Part of Bioivt, LLC
- UEI
- MAQKL1MN66A9
- CAGE
- 1NH38
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Bioivt, LLC, ranks #45 in NAICS 325414
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Woodbury, NY
L2BGKGC6LJW7
-
Parent
Woodbury, NY
L2BGKGC6LJW7
- SAM.gov registration date
- Physical address
- 1101 W Cambridge Cir Dr, Kansas City, KS 66103, USA
- Website
- bioivt.com
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$71,919 |
| FY2024 | $25,333 |
| FY2023 | $45,717 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Enzyme induction in freshly isolated human hepatocytes | National Institutes of Health | -$95,765 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Neucyte Inc. | Mountain View, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Insphero, Inc. | Portland, ME | 325414 Biological Product (except Diagnostic) Manufacturing |
| Bioivt, LLC | Woodbury, NY | 325414 Biological Product (except Diagnostic) Manufacturing |
| Mirimus, Inc. | NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| AAT Bioquest Inc. | Pleasanton, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Xenotech LLC, doing business as Sekisui-Xenotech, is a corporate entity registered to receive federal contract and grant awards since November 1999. The company specializes in providing biomedical research materials and services to various federal agencies, particularly in the areas of drug metabolism and drug-drug interaction studies for preclinical drug development. As a self-certified small disadvantaged business, Xenotech has established itself as a key supplier of cryopreserved human hepatocytes, liver microsomes, and related professional services to support federal research and development programs.
Recent federal contract awards demonstrate Xenotech's significant contributions to biomedical research across multiple agencies. The Environmental Protection Agency's Office of Research and Development awarded a $25,333 contract for cryopreserved human hepatocytes in March 2024. The National Institutes of Health's National Center for Advancing Translational Sciences contracted $45,717 worth of cryopreserved human, mouse, and rat hepatocytes in August 2023 to support malaria research. The Food and Drug Administration engaged Xenotech for protein binding assays of targets/receptors in August 2021, while the National Institute on Drug Abuse procured mixed gender human liver microsomes for $41,496 in August 2019 to support the Tox21 program. Additionally, Xenotech has served as a subcontractor to prime contractors such as Battelle Memorial Institute and Westat, Inc., providing HeptaSure pooled cryopreserved human hepatocytes and professional services, respectively. These awards, predominantly structured as firm fixed price purchase orders without set-aside designations, underscore Xenotech's crucial role in supplying specialized biological materials and expertise to advance federal biomedical research initiatives.
SBA capabilities narrative
ADME-tox, Induction, Inhibition, contract research organization, hepatocytes, microsomes, in vitro, transporters, P450, enzyme, drug-drug interaction studies, subcellular fractions, animal, human, transporters, metabolite identification and quantification
Quick answers
Is Xenotech LLC registered in SAM.gov?
Yes. Xenotech LLC's SAM.gov registration is active through February 17, 2027.
How does Xenotech LLC rank among federal contractors?
Xenotech LLC's parent company, Bioivt, LLC, ranked #45 in NAICS 325414 in FY2025.
What is Xenotech LLC's most recent federal award?
Xenotech LLC's most recent federal contract award is Cryostax cryopreserved human hepatocytes, QTY 21 vials (68HE0B24P0354), from Office of Research and Development (EPA), on March 7, 2024.
On GovTribe
See Xenotech LLC's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors